CN110170008A - A kind of female ovulatory period is using assigning molecule essential oils living and preparation method thereof - Google Patents
A kind of female ovulatory period is using assigning molecule essential oils living and preparation method thereof Download PDFInfo
- Publication number
- CN110170008A CN110170008A CN201910478529.7A CN201910478529A CN110170008A CN 110170008 A CN110170008 A CN 110170008A CN 201910478529 A CN201910478529 A CN 201910478529A CN 110170008 A CN110170008 A CN 110170008A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil
- living
- essential oils
- tocopherol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 55
- 230000000624 ovulatory effect Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000003921 oil Substances 0.000 claims abstract description 124
- 235000019198 oils Nutrition 0.000 claims abstract description 124
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 22
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 20
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 20
- 244000179970 Monarda didyma Species 0.000 claims abstract description 20
- 235000010672 Monarda didyma Nutrition 0.000 claims abstract description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims abstract description 20
- 235000019719 rose oil Nutrition 0.000 claims abstract description 20
- 239000010666 rose oil Substances 0.000 claims abstract description 20
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 20
- 239000011732 tocopherol Substances 0.000 claims abstract description 20
- 229960001295 tocopherol Drugs 0.000 claims abstract description 20
- 229930003799 tocopherol Natural products 0.000 claims abstract description 20
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 20
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 20
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims abstract description 19
- 235000019477 peppermint oil Nutrition 0.000 claims abstract description 19
- 235000004692 Eucalyptus globulus Nutrition 0.000 claims abstract description 18
- 235000019134 Eucalyptus tereticornis Nutrition 0.000 claims abstract description 18
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 18
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims abstract description 17
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000008169 grapeseed oil Substances 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 244000044822 Simmondsia californica Species 0.000 claims abstract 5
- 244000269722 Thea sinensis Species 0.000 claims abstract 4
- 238000003756 stirring Methods 0.000 claims description 42
- -1 ethylhexyl Chemical group 0.000 claims description 14
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 7
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 7
- 229940106189 ceramide Drugs 0.000 claims description 7
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 7
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 7
- 238000010792 warming Methods 0.000 claims description 7
- 244000283207 Indigofera tinctoria Species 0.000 claims description 2
- 239000010642 eucalyptus oil Substances 0.000 claims description 2
- 229940044949 eucalyptus oil Drugs 0.000 claims description 2
- 244000166124 Eucalyptus globulus Species 0.000 claims 3
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 240000007002 Eucalyptus tereticornis Species 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 241001122767 Theaceae Species 0.000 description 15
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 14
- 241000221095 Simmondsia Species 0.000 description 13
- 235000009754 Vitis X bourquina Nutrition 0.000 description 6
- 235000012333 Vitis X labruscana Nutrition 0.000 description 6
- 240000006365 Vitis vinifera Species 0.000 description 6
- 235000014787 Vitis vinifera Nutrition 0.000 description 6
- 230000016087 ovulation Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 4
- 210000004696 endometrium Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 206010024642 Listless Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008094 contradictory effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 230000001072 progestational effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- 240000007175 Datura inoxia Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- QMHBZWNZCSNBGU-UHFFFAOYSA-N nonane-1,2,3-triol Chemical compound CCCCCCC(O)C(O)CO QMHBZWNZCSNBGU-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
It includes the raw material of following parts by weight: 10-30 parts of grape seed oil, 10-20 parts of rose oil, 6-10 parts of sweet orange peel oil, 10-20 parts of bergamot fruit oil, 15-25 parts of tea leaf oil, 10-20 parts of blue gum leaf oil, 8-16 parts of peppermint oil, 4-10 parts of lavender oil, 8-20 parts of tocopherol, 20-30 parts, 25-28 parts of jojoba seed oil of Ci Agan tree benevolence oil that the invention discloses a kind of female ovulatory periods using molecule essential oils living and preparation method thereof, tax molecule essential oils living are assigned；50-60 parts of isohexadecane, 2-6 parts of Sensiva SC50,0-12 parts of Cer EOS.The production method of female ovulatory period of the invention using molecule essential oils living are assigned, including prefabricated foundation oil, multiple processing steps such as prepare essential oil, mixing, do to improve can achieve the effect reinforced the kidney, may also help in women and smoothly ovulate.
Description
Technical field
The present invention relates to female health product technical fields more particularly to a kind of female ovulatory period to use tax molecule essential oils living
And preparation method thereof.
Background technique
Determining female physiological periodicity is divided into the onset of ovulation, the onset of ovulation, nourishing phase and onset of ovulation four-stage.The women of child-bearing age are every one
Month or so, endometrium generation once independently thickens, and blood vessel hyperplasia, body of gland growth are secreted and endometrium collapse falls off and companion
With the cyclically-varying of bleeding, this periodicity vaginal haemorrhage or uterine hemorrhage phenomenon are known as menstruation.The side that menstrual cycle calculates
Method was counted from upper a menstruation first day, after 28 days be exactly second of menstrual period, but due to constitution, the age, weather,
The difference in area and living condition, menstrual cycle also difference all can belong to normal range (NR) in the range of 7 days before and after 28 days.
Generally by first day starting point as a cycle of each menstrual onset, at this time estrogen and progestational hormone all in
Neap；Then, estrogen level gradually rises, and spike is reached after 2 weeks, and body starts to ovulate.We can be by this period
Referred to as " onset of ovulation ".Next, progesterone level gradually increases, so that endometrial thickness, supply of blood flow more horn of plenty, just like
The fertile soil of waiting sowing is just " seed " once becoming pregnant --- fertilized eggs provide nutrient abundant.It is female to swash if do not become pregnant
Element and progestational hormone sharply decline, and atrophy of endometrium, necrosis, falls off at hyperemia, form menstruation.Meeting during this complexity
Various inferior healths are brought to women.
Summary of the invention
The present invention is directed to above-mentioned problem, provides a kind of female ovulatory period using assigning molecule essential oils living and its production side
Method.
To achieve the goals above, the invention provides the following technical scheme:
The present invention provides a kind of female ovulatory period use tax molecule essential oils living, the raw material including following parts by weight: grape
10-30 parts of seed oil, 10-20 parts of rose oil, 6-10 parts of sweet orange peel oil, 10-20 parts of bergamot fruit oil, 15-25 parts of tea leaf oil,
10-20 parts of blue gum leaf oil, 8-16 parts of peppermint oil, 4-10 parts of lavender oil, 8-20 parts of tocopherol, 20-30 parts of Ci Agan tree benevolence oil,
25-28 parts of jojoba seed oil；50-60 parts of isohexadecane, 2-6 parts of Sensiva SC50,0-12 parts of Cer EOS.
Preferably, above-mentioned female ovulatory period uses tax molecule essential oils living, the raw material including following parts by weight: Portugal
10-16 parts of grape seed oil, 8-13 parts of rose oil, 5-7 parts of sweet orange peel oil, 6-8 parts of bergamot fruit oil, 9-11 parts of tea leaf oil, indigo plant
10-14 parts of eucalyptus oil, 4-6 parts of peppermint oil, 3-7 parts of lavender oil, 7-12 parts of tocopherol, 22-26 parts of Ci Agan tree benevolence oil, flash
Bars 25-28 parts of seed oil；54-56 parts of isohexadecane, 2-6 parts of Sensiva SC50,0-12 parts of Cer EOS.
Preferably, above-mentioned female ovulatory period uses tax molecule essential oils living, the raw material including following parts by weight: Portugal
13 parts of grape seeds oil, 10 parts of rose oil, 6 parts of sweet orange peel oil, 7 parts of bergamot fruit oil, 10 parts of tea leaf oil, 12 parts of blue gum leaf oil,
5 parts of peppermint oil, 5 parts of lavender oil, 9 parts of tocopherol, 24 parts, 26 parts of jojoba seed oil of oil of Ci Agan tree benevolence；55 parts of isohexadecane,
4 parts of Sensiva SC50,1 part of Cer EOS.
Production method the present invention also provides above-mentioned female ovulatory period using molecule essential oils living are assigned, including following step
It is rapid:
S1 prefabricated foundation oil
Under stirring conditions, Ci Agan tree benevolence oil, jojoba seed oil are added into reactor；Isohexadecane, ethyl hexyl
Base glycerol, ceramide are warming up to 55~60 DEG C, are stirred, and are cooled to 40~45 DEG C, stir evenly, obtain prefabricated foundation
Oil；
S2 prepares essential oil
Under stirring, grape seed oil, rose oil, sweet orange peel oil, bergamot fruit are sequentially added into reactor
Oil, tea leaf oil, blue gum leaf oil, peppermint oil, lavender oil, stir evenly, and tocopherol is added, continues to stir, and are uniformly mixed, obtain
Essential oil；
S3 under stirring conditions, essential oil prepared by step S2 is added into step S1 prefabricated foundation oil, is uniformly mixed, mistake
Filter, obtains assigning molecule essential oils living.
Compared with prior art, the invention has the benefit that
The present invention solves the problems, such as that female ovulatory period since kidney deficiency occurs in kidney, avoids the onset of ovulation from occurring, energy overdraw, essence
Mind is spent freely excessively, and face is caused: color spot, the colour of skin are obscure；Body: indefinite, implication is unpleasant, listless, vivotoxin deposition, new
Old metabolism slows down, vigor reduces, a small amount of the last week syndrome problem；Soul: light, happy, nervous, contradictory psychology etc. is existing
Row；Doing conditioning can achieve the effect reinforced the kidney, and may also help in women and smoothly ovulates；Whole process conditioning can achieve the effect of moistening lung
Fruit.
Female ovulatory period provided by the invention is using molecule essential oils living are assigned, with grape seed oil, rose oil, sweet orange pericarp
Oil, bergamot fruit oil, tea leaf oil, blue gum leaf oil, peppermint oil, lavender oil, tocopherol are primary raw material, make full use of its nutrition
The abundant and advantage with certain health-care efficacy.
Specific embodiment
Embodiment 1
The present invention provides a kind of female ovulatory periods to use tax molecule essential oils living, the raw material including following parts by weight: Portugal
10 parts of grape seeds oil, 10 parts of rose oil, 6 parts of sweet orange peel oil, 10 parts of bergamot fruit oil, 15 parts of tea leaf oil, 10 parts of blue gum leaf oil,
8 parts of peppermint oil, 4 parts of lavender oil, 8 parts of tocopherol, 20 parts, 25 parts of jojoba seed oil of oil of Ci Agan tree benevolence；50 parts of isohexadecane,
2 parts of Sensiva SC50,0 part of Cer EOS.
Production method the present invention also provides above-mentioned female ovulatory period using molecule essential oils living are assigned, including following step
It is rapid:
S1 prefabricated foundation oil
Under stirring conditions, Ci Agan tree benevolence oil, jojoba seed oil are added into reactor；Isohexadecane, ethyl hexyl
Base glycerol, ceramide are warming up to 55 DEG C, are stirred, and are cooled to 40 DEG C, stir evenly, and obtain prefabricated foundation oil；
S2 prepares essential oil
Under stirring, grape seed oil, rose oil, sweet orange peel oil, bergamot fruit are sequentially added into reactor
Oil, tea leaf oil, blue gum leaf oil, peppermint oil, lavender oil, stir evenly, and tocopherol is added, continues to stir, and are uniformly mixed, obtain
Essential oil；
S3 under stirring conditions, essential oil prepared by step S2 is added into step S1 prefabricated foundation oil, is uniformly mixed, mistake
Filter, obtains assigning molecule essential oils living.
Embodiment 2
The present invention provides a kind of female ovulatory periods to use tax molecule essential oils living, the raw material including following parts by weight: Portugal
30 parts of grape seed oil, 20 parts of rose oil, 10 parts of sweet orange peel oil, bergamot fruit oily 20 parts, 25 parts of tea leaf oil, blue gum leaf oil 20
Part, 16 parts of peppermint oil, 10 parts of lavender oil, 20 parts of tocopherol, 30 parts, 28 parts of jojoba seed oil of oil of Ci Agan tree benevolence；Different 16
60 parts of alkane, 6 parts of Sensiva SC50,2 parts of Cer EOS.
Production method the present invention also provides above-mentioned female ovulatory period using molecule essential oils living are assigned, including following step
It is rapid:
S1 prefabricated foundation oil
Under stirring conditions, Ci Agan tree benevolence oil, jojoba seed oil are added into reactor；Isohexadecane, ethyl hexyl
Base glycerol, ceramide are warming up to 60 DEG C, are stirred, and are cooled to 45 DEG C, stir evenly, and obtain prefabricated foundation oil；
S2 prepares essential oil
Under stirring, grape seed oil, rose oil, sweet orange peel oil, bergamot fruit are sequentially added into reactor
Oil, tea leaf oil, blue gum leaf oil, peppermint oil, lavender oil, stir evenly, and tocopherol is added, continues to stir, and are uniformly mixed, obtain
Essential oil；
S3 under stirring conditions, essential oil prepared by step S2 is added into step S1 prefabricated foundation oil, is uniformly mixed, mistake
Filter, obtains assigning molecule essential oils living.
Embodiment 3
The present invention provides a kind of female ovulatory periods to use tax molecule essential oils living, the raw material including following parts by weight: Portugal
It is 10 parts of grape seeds oil, 8 parts of rose oil, 5 parts of sweet orange peel oil, 6 parts of bergamot fruit oil, 9 parts of tea leaf oil, 10 parts of blue gum leaf oil, thin
4 parts of lotus oil, 3 parts of lavender oil, 7 parts of tocopherol, 22 parts, 25 parts of jojoba seed oil of oil of Ci Agan tree benevolence；54 parts of isohexadecane, second
2 parts of base hexyl glycerol, 0 part of Cer EOS.
Production method the present invention also provides above-mentioned female ovulatory period using molecule essential oils living are assigned, including following step
It is rapid:
S1 prefabricated foundation oil
Under stirring conditions, Ci Agan tree benevolence oil, jojoba seed oil are added into reactor；Isohexadecane, ethyl hexyl
Base glycerol, ceramide are warming up to 55 DEG C, are stirred, and are cooled to 40 DEG C, stir evenly, and obtain prefabricated foundation oil；
S2 prepares essential oil
Under stirring, grape seed oil, rose oil, sweet orange peel oil, bergamot fruit are sequentially added into reactor
Oil, tea leaf oil, blue gum leaf oil, peppermint oil, lavender oil, stir evenly, and tocopherol is added, continues to stir, and are uniformly mixed, obtain
Essential oil；
S3 under stirring conditions, essential oil prepared by step S2 is added into step S1 prefabricated foundation oil, is uniformly mixed, mistake
Filter, obtains assigning molecule essential oils living.
Embodiment 4
The present invention provides a kind of female ovulatory periods to use tax molecule essential oils living, the raw material including following parts by weight: Portugal
16 parts of grape seeds oil, 13 parts of rose oil, 7 parts of sweet orange peel oil, 8 parts of bergamot fruit oil, 11 parts of tea leaf oil, 14 parts of blue gum leaf oil,
6 parts of peppermint oil, 7 parts of lavender oil, 12 parts of tocopherol, 26 parts, 28 parts of jojoba seed oil of oil of Ci Agan tree benevolence；Isohexadecane 56
Part, 6 parts of Sensiva SC50,2 parts of Cer EOS.
Production method the present invention also provides above-mentioned female ovulatory period using molecule essential oils living are assigned, including following step
It is rapid:
S1 prefabricated foundation oil
Under stirring conditions, Ci Agan tree benevolence oil, jojoba seed oil are added into reactor；Isohexadecane, ethyl hexyl
Base glycerol, ceramide are warming up to 60 DEG C, are stirred, and are cooled to 45 DEG C, stir evenly, and obtain prefabricated foundation oil；
S2 prepares essential oil
Under stirring, grape seed oil, rose oil, sweet orange peel oil, bergamot fruit are sequentially added into reactor
Oil, tea leaf oil, blue gum leaf oil, peppermint oil, lavender oil, stir evenly, and tocopherol is added, continues to stir, and are uniformly mixed, obtain
Essential oil；
S3 under stirring conditions, essential oil prepared by step S2 is added into step S1 prefabricated foundation oil, is uniformly mixed, mistake
Filter, obtains assigning molecule essential oils living.
Embodiment 5
The present invention provides a kind of female ovulatory periods to use tax molecule essential oils living, the raw material including following parts by weight: Portugal
13 parts of grape seeds oil, 10 parts of rose oil, 6 parts of sweet orange peel oil, 7 parts of bergamot fruit oil, 10 parts of tea leaf oil, 12 parts of blue gum leaf oil,
5 parts of peppermint oil, 5 parts of lavender oil, 9 parts of tocopherol, 24 parts, 26 parts of jojoba seed oil of oil of Ci Agan tree benevolence；55 parts of isohexadecane,
4 parts of Sensiva SC50,1 part of Cer EOS.
Production method the present invention also provides above-mentioned female ovulatory period using molecule essential oils living are assigned, including following step
It is rapid:
S1 prefabricated foundation oil
Under stirring conditions, Ci Agan tree benevolence oil, jojoba seed oil are added into reactor；Isohexadecane, ethyl hexyl
Base glycerol, ceramide are warming up to 55 DEG C, are stirred, and are cooled to 40 DEG C, stir evenly, and obtain prefabricated foundation oil；
S2 prepares essential oil
Under stirring, grape seed oil, rose oil, sweet orange peel oil, bergamot fruit are sequentially added into reactor
Oil, tea leaf oil, blue gum leaf oil, peppermint oil, lavender oil, stir evenly, and tocopherol is added, continues to stir, and are uniformly mixed, obtain
Essential oil；
S3 under stirring conditions, essential oil prepared by step S2 is added into step S1 prefabricated foundation oil, is uniformly mixed, mistake
Filter, obtains assigning molecule essential oils living.
The present invention solves the problems, such as that female ovulatory period since kidney deficiency occurs in kidney, avoids the onset of ovulation from occurring, energy overdraw, essence
Mind is spent freely excessively, and face is caused: color spot, the colour of skin are obscure；Body: indefinite, implication is unpleasant, listless, vivotoxin deposition, new
Old metabolism slows down, vigor reduces, a small amount of the last week syndrome problem；Soul: light, happy, nervous, contradictory psychology etc. is existing
Row；Doing conditioning can achieve the effect reinforced the kidney, and may also help in women and smoothly ovulates；Whole process conditioning can achieve the effect of moistening lung
Fruit.
It is above that certain exemplary embodiments of the invention are only described by way of explanation, undoubtedly, for ability
The those of ordinary skill in domain without departing from the spirit and scope of the present invention can be with a variety of different modes to institute
The embodiment of description is modified.Therefore, foregoing description is regarded as illustrative in nature, and should not be construed as wanting right of the present invention
Ask the limitation of protection scope.
Claims (4)
1. a kind of female ovulatory period is using assigning molecule essential oils living, which is characterized in that the raw material including following parts by weight: including with
The raw material of lower parts by weight: 10-30 parts of grape seed oil, 10-20 parts of rose oil, 6-10 parts of sweet orange peel oil, bergamot fruit oil 10-
20 parts, 15-25 parts of tea leaf oil, 10-20 parts of blue gum leaf oil, 8-16 parts of peppermint oil, 4-10 parts of lavender oil, 8-20 parts of tocopherol,
20-30 parts, 25-28 parts of jojoba seed oil of Ci Agan tree benevolence oil；50-60 parts of isohexadecane, 2-6 parts of Sensiva SC50, nerve
10-12 parts of amide.
2. female ovulatory period according to claim 1 uses tax molecule essential oils living, which is characterized in that including following weight
The raw material of part: 10-16 parts of grape seed oil, 8-13 parts of rose oil, 5-7 parts of sweet orange peel oil, 6-8 parts of bergamot fruit oil, tealeaves
9-11 parts oily, 10-14 parts of blue gum leaf oil, 4-6 parts of peppermint oil, 3-7 parts of lavender oil, 7-12 parts of tocopherol, Ci Agan tree benevolence oil
22-26 parts, 25-28 parts of jojoba seed oil；54-56 parts of isohexadecane, 2-6 parts of Sensiva SC50,0-12 parts of Cer EOS.
3. female ovulatory period according to claim 2 uses tax molecule essential oils living, which is characterized in that including following weight
The raw material of part: 13 parts of grape seed oil, 10 parts of rose oil, 6 parts of sweet orange peel oil, 7 parts of bergamot fruit oil, 10 parts of tea leaf oil, indigo plant
12 parts of eucalyptus oil, 5 parts of peppermint oil, 5 parts of lavender oil, 9 parts of tocopherol, 24 parts, 26 parts of jojoba seed oil of oil of Ci Agan tree benevolence；It is different
55 parts of hexadecane, 4 parts of Sensiva SC50,1 part of Cer EOS.
4. production method of the female ovulatory period according to claim 1 using molecule essential oils living are assigned, which is characterized in that packet
Include following steps:
S1 prefabricated foundation oil
Under stirring conditions, Ci Agan tree benevolence oil, jojoba seed oil are added into reactor；Isohexadecane, ethylhexyl are sweet
Oil, ceramide, are warming up to 55~60 DEG C, are stirred, be cooled to 40~45 DEG C, stir evenly, and obtain prefabricated foundation oil；
S2 prepares essential oil
Under stirring, grape seed oil, rose oil, sweet orange peel oil, bergamot fruit oil, tea are sequentially added into reactor
Leaf oil, blue gum leaf oil, peppermint oil, lavender oil, stir evenly, and tocopherol is added, continues to stir, and are uniformly mixed, obtain essential oil；
S3 under stirring conditions, essential oil prepared by step S2 is added into step S1 prefabricated foundation oil, is uniformly mixed, filtering,
It obtains assigning molecule essential oils living.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910478529.7A CN110170008A (en) | 2019-06-03 | 2019-06-03 | A kind of female ovulatory period is using assigning molecule essential oils living and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910478529.7A CN110170008A (en) | 2019-06-03 | 2019-06-03 | A kind of female ovulatory period is using assigning molecule essential oils living and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110170008A true CN110170008A (en) | 2019-08-27 |
Family
ID=67697631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910478529.7A Pending CN110170008A (en) | 2019-06-03 | 2019-06-03 | A kind of female ovulatory period is using assigning molecule essential oils living and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110170008A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111956727A (en) * | 2020-07-08 | 2020-11-20 | 颜云 | Molecular refined oil for regulating female physiological cycle |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107441002A (en) * | 2017-09-25 | 2017-12-08 | 湖南爱瑞西诗生命科技有限公司 | A kind of essential oils |
| CN111956727A (en) * | 2020-07-08 | 2020-11-20 | 颜云 | Molecular refined oil for regulating female physiological cycle |
-
2019
- 2019-06-03 CN CN201910478529.7A patent/CN110170008A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107441002A (en) * | 2017-09-25 | 2017-12-08 | 湖南爱瑞西诗生命科技有限公司 | A kind of essential oils |
| CN111956727A (en) * | 2020-07-08 | 2020-11-20 | 颜云 | Molecular refined oil for regulating female physiological cycle |
Non-Patent Citations (1)
| Title |
|---|
| 广东美之源生物科技股份有限公司: "聚美以程赋活分子油二号", 《HTTPS://HZPBA.NMPA.GOV.CN/GCCX/CHAKANHIS.HTML?PRODID=20180413102734NKK67&GB=G》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111956727A (en) * | 2020-07-08 | 2020-11-20 | 颜云 | Molecular refined oil for regulating female physiological cycle |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110170008A (en) | A kind of female ovulatory period is using assigning molecule essential oils living and preparation method thereof | |
| KR101085948B1 (en) | Composite for hair promotion, manufacturing method thereof | |
| CN111956727A (en) | Molecular refined oil for regulating female physiological cycle | |
| CN113648271A (en) | Hair loss prevention and hair growth composition and preparation method thereof | |
| CN105078827B (en) | A kind of functions of nourishing hair and growing hair liquid containing shrubby sophora extract | |
| JP2009191012A (en) | Infertility treating agent containing oleuropein, oleuropein derivative or hydroxytyrosol as active component | |
| CN106236656B (en) | A kind of compact eye cream of rosemary | |
| CN108815316A (en) | Breast fitness conditioning compound borneol essential oil and preparation method thereof | |
| CN110123918A (en) | A kind of women estrus is using assigning molecule essential oils living and preparation method thereof | |
| CN110101779A (en) | A kind of women luteal phase is using assigning molecule essential oils living and preparation method thereof | |
| CN111249182B (en) | Tranquilizing composition and application thereof in perfume | |
| CN108078827A (en) | A kind of hair growth accelerating shampoo and preparation method thereof | |
| CN105943476A (en) | Vanilla planifolia essence hair conditioner | |
| EP3638198B1 (en) | Composition to prevent hairloss and promote hairgrowth | |
| CN110101778A (en) | A kind of women physiological period is using assigning molecule essential oils living and preparation method thereof | |
| CN107412054B (en) | Hair-growing shampoo and preparation method thereof | |
| CN101020036A (en) | Externally applied prepn for treating trauma and its prepn process | |
| CN110075238A (en) | A kind of plant extracts gel that treating hemorrhoid and preparation method | |
| AT505539A4 (en) | Cosmetic body care composition, useful for treating skin diseases, preferably neurodermitis, comprises mixture of herb extract including Radix paeoniae, Bulbus lilii, Radix rehmanniae viridans, Radix scrophulariae or Rhizoma anemarrhenae | |
| CN1899553A (en) | Paste for treating dental hyperesthesia and its preparing method | |
| KR20160134954A (en) | A manufacturing method of cactus fermented liquid and cactus fermented liquid manufactured therefrom | |
| CN1240414C (en) | Prepared Chinese medicine for improving function of female ovary as well as preparation method and application in pharmacy | |
| CN1151792C (en) | Use of anti-oestrogens as male contraceptives | |
| CN1190225C (en) | Oral medication germinal preparation and making process thereof | |
| CN108812936A (en) | A kind of fragrance of a flower corn ready-mixed oil and its production technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190827 |